ING Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.73M | Sell |
111,463
-96,335
| -46% | -$8.41M | 0.06% | 173 |
|
|
2025
Q1 | $14.2M | Buy |
207,798
+131,195
| +171% | +$8.96M | 0.1% | 136 |
|
|
2024
Q4 | $5.96M | Buy |
76,603
+43,688
| +133% | +$3.4M | 0.04% | 258 |
|
|
2024
Q3 | $2.21M | Sell |
32,915
-56,662
| -63% | -$3.8M | 0.01% | 410 |
|
|
2024
Q2 | $10.2M | Buy |
+89,577
| New | +$10.2M | 0.06% | 224 |
|
|
2023
Q4 | – | Sell |
-5,617
| Closed | -$524K | – | 585 |
|
|
2023
Q3 | $524K | Sell |
5,617
-32,946
| -85% | -$3.07M | ﹤0.01% | 484 |
|
|
2023
Q2 | $4.96M | Buy |
38,563
+36,137
| +1,490% | +$4.64M | 0.04% | 259 |
|
|
2023
Q1 | $282K | Sell |
2,426
-88,348
| -97% | -$10.3M | ﹤0.01% | 501 |
|
|
2022
Q4 | $10.3M | Buy |
+90,774
| New | +$10.3M | 0.1% | 153 |
|
|
2022
Q1 | – | Sell |
-67,072
| Closed | -$9M | – | 550 |
|
|
2021
Q4 | $9M | Buy |
67,072
+27,768
| +71% | +$3.73M | 0.08% | 193 |
|
|
2021
Q3 | $5.37M | Buy |
39,304
+712
| +2% | +$97.3K | 0.07% | 185 |
|
|
2021
Q2 | $4.12M | Buy |
38,592
+13,120
| +52% | +$1.4M | 0.07% | 185 |
|
|
2021
Q1 | $2.29M | Sell |
25,472
-4
| -0% | -$359 | 0.05% | 226 |
|
|
2020
Q4 | $2.36M | Buy |
25,476
+17,000
| +201% | +$1.57M | 0.05% | 211 |
|
|
2020
Q3 | $874K | Buy |
8,476
+5,352
| +171% | +$552K | 0.04% | 213 |
|
|
2020
Q2 | $317K | Buy |
+3,124
| New | +$317K | 0.01% | 216 |
|